| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 2,4 M € | -6.0% | 2,5 M € | -14.4% | 3,0 M € | +7.0% | 2,8 M € | +15.7% | 2,4 M € | +16.6% | 2,1 M € | -18.4% | 2,5 M € | +5.7% | 2,4 M € | -4.1% | 2,5 M € | +0.2% | 2,5 M € | +20.8% | 2,1 M € | +21.3% | 1,7 M € | +9.9% | 1,5 M € | +17.4% | 1,3 M € | +16.2% | 1,1 M € | +29.5% | 874,4 k € | +44.1% | 606,8 k € | -31.2% | 881,9 k € | +7.0% | 824,3 k € | |
| EBITDA | -449,0 k € | +50.2% | -901,3 k € | -221.5% | 741,8 k € | -18.6% | 911,4 k € | +4.5% | 872,1 k € | +73.9% | 501,4 k € | +31.1% | 382,4 k € | -51.3% | 784,5 k € | +10.5% | 710,2 k € | -5.3% | 749,7 k € | +9.3% | 685,8 k € | +26.4% | 542,4 k € | +7.5% | 504,6 k € | -6.6% | 540,0 k € | -1.7% | 549,5 k € | +62.3% | 338,5 k € | +558476.6% | 60,6 € | -99.6% | 15,2 k € | -92.9% | 214,8 k € | |
| Operating profit | -1,0 M € | +48.3% | -2,0 M € | -12434.8% | 16,4 k € | -93.2% | 242,7 k € | +263.7% | 66,7 k € | +193.9% | 22,7 k € | +104.1% | -550,2 k € | -3283.1% | 17,3 k € | -37.4% | 27,6 k € | -57.9% | 65,6 k € | -55.8% | 148,6 k € | +70.2% | 87,3 k € | -31.1% | 126,7 k € | -40.0% | 211,2 k € | -22.0% | 271,0 k € | +95.2% | 138,8 k € | +166.8% | -207,7 k € | +75.6% | -850,9 k € | -3566.6% | 24,5 k € | |
| Profit/loss | -1,4 M € | +42.1% | -2,5 M € | -1323.3% | -172,6 k € | -195.9% | 180,0 k € | +5874.3% | 3,0 k € | -50.3% | 6,1 k € | +101.1% | -550,1 k € | -10968.0% | 5,1 k € | -69.8% | 16,8 k € | -0.8% | 16,9 k € | -85.0% | 112,5 k € | +193.0% | 38,4 k € | +93.2% | 19,9 k € | -14.6% | 23,3 k € | -52.8% | 49,3 k € | +99.2% | 24,7 k € | +113.0% | -190,5 k € | -182.8% | 230,1 k € | +205.1% | -218,9 k € | |
| Equity | -2,6 M € | -116.7% | -1,2 M € | -198.3% | 1,2 M € | -12.2% | 1,4 M € | +12.0% | 1,3 M € | -3.0% | 1,3 M € | -2.7% | 1,3 M € | -30.7% | 1,9 M € | +5.8% | 1,8 M € | +0.2% | 1,8 M € | +3.2% | 1,8 M € | +3.3% | 1,7 M € | +1.7% | 1,7 M € | +0.6% | 1,7 M € | +42.5% | 1,2 M € | +3.9% | 1,1 M € | +140.5% | 469,6 k € | -30.7% | 677,8 k € | -10.6% | 758,2 k € | |
| Total assets | 6,5 M € | +6.7% | 6,1 M € | -17.6% | 7,4 M € | +9.9% | 6,7 M € | +14.2% | 5,9 M € | +4.3% | 5,6 M € | -9.2% | 6,2 M € | +0.5% | 6,2 M € | +0.9% | 6,1 M € | +8.7% | 5,6 M € | +21.9% | 4,6 M € | +7.5% | 4,3 M € | +10.3% | 3,9 M € | +16.3% | 3,3 M € | +16.8% | 2,9 M € | +15.0% | 2,5 M € | +13.8% | 2,2 M € | +4.9% | 2,1 M € | -42.5% | 3,6 M € | |
| Cash | 449,8 k € | +43.5% | 313,4 k € | +10.4% | 283,8 k € | +39.4% | 203,6 k € | -28.7% | 285,4 k € | +361.2% | 61,9 k € | +16.4% | 53,2 k € | -58.5% | 128,1 k € | -76.2% | 538,0 k € | +7340.8% | 7,2 k € | -62.1% | 19,1 k € | +6.8% | 17,9 k € | -88.6% | 156,5 k € | +116.0% | 72,5 k € | +35.0% | 53,7 k € | +68.9% | 31,8 k € | +31.2% | 24,2 k € | +276.6% | 6,4 k € | -97.4% | 251,0 k € | |
| Debts | 9,0 M € | +29.8% | 7,0 M € | +14.4% | 6,1 M € | +15.1% | 5,3 M € | +14.8% | 4,6 M € | +6.4% | 4,3 M € | -11.0% | 4,9 M € | +14.8% | 4,2 M € | -1.1% | 4,3 M € | +12.7% | 3,8 M € | +33.7% | 2,8 M € | +10.5% | 2,6 M € | +17.0% | 2,2 M € | +32.5% | 1,7 M € | -0.7% | 1,7 M € | +24.8% | 1,3 M € | -20.1% | 1,7 M € | +21.9% | 1,4 M € | -50.8% | 2,8 M € | |
| Staff | 42,3 | 46,2 | 41,1 | 37,4 | 33,2 | 35,4 | 42,3 | 38,5 | 42,8 | 39,3 | 34,3 | 28,9 | 26,1 | 22,1 | 19,2 | 18,2 | 18,6 | 20,7 | 19,8 | |||||||||||||||||||
Public limited company · Mons · incorporated on 08/12/1997 · 42,3 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+43.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
HEDELAB is a Public limited company incorporated in 1997. Its main activity is: Manufacture of homogenised food preparations and dietetic food. Its registered office is in Mons. It employs on average 42,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette